Nuchev Ltd (ASX: NUC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Nuchev Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$21.17 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
156.82 million
Earnings per share
-0.026
Dividend per share
N/A
Year To Date Return
8.00%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Nuchev Ltd (ASX: NUC)
Latest News
Share Market News
Forget a2 Milk! Why these 3 ASX baby formula stocks could soar in 2020
Share Gainers
Is this infant formula company the next a2 Milk Company?
Growth Shares
Where to invest $5,000 in ASX growth shares right now
❮2
NUC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Nuchev Ltd
Nuchev Ltd is a globally-oriented food business focused on developing, marketing, and selling a range of premium Australian made goat nutritional products. Its products include those branded under the Oli6 Bio Practica and Medicine Tree and a number of globally recognized European brands sold under exclusive license in Australia and New Zealand by bWellness.
NUC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 02 Feb 2026 | $0.14 | $0.01 | 8.00% | 158 | $0.14 | $0.14 | $0.14 |
| 29 Jan 2026 | $0.13 | $-0.01 | -7.41% | 50,506 | $0.13 | $0.15 | $0.13 |
| 14 Jan 2026 | $0.14 | $0.00 | 0.00% | 34,885 | $0.14 | $0.14 | $0.14 |
| 08 Jan 2026 | $0.14 | $0.01 | 7.69% | 4,043 | $0.13 | $0.14 | $0.13 |
| 07 Jan 2026 | $0.13 | $0.00 | 0.00% | 150 | $0.13 | $0.13 | $0.13 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 22 Jan 2026 | Ben Dingle | Issued | 479,102 | $64,678 |
Conversion of securities. Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $61,325.00.
|
| 22 Jan 2026 | Ben Dingle | Exercise | 479,102 | $64,678 |
Conversion of securities. 354,210 Share Rights, Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $61,325.00.
|
| 22 Jan 2026 | Elizabeth Smith (Liz) | Exercise | 278,750 | $37,631 |
Conversion of securities. Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $35,680.00. 212,267 Rights
|
| 22 Jan 2026 | Elizabeth Smith (Liz) | Issued | 278,750 | $37,631 |
Conversion of securities. Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $35,680.00.
|
| 22 Jan 2026 | Craig Silbery | Exercise | 474,746 | $64,090 |
Conversion of securities. Non-cash consideration: Share Rights issued under the Equity Incentive Plan, in lieu of payment of Directors fees of $60,768.00. 350,990 Share Rights
|
| 22 Jan 2026 | Craig Silbery | Issued | 474,746 | $64,090 |
Conversion of securities. As per announcement on 22/01/2026
|
| 04 Dec 2025 | Meng (Leo) Zhang | Issued | 385,454 | $67,033 |
Director remuneration. Unquoted Share Rights 385,454
|
| 31 Oct 2025 | Elizabeth Smith (Liz) | Issued | 212,267 | $36,915 |
Director remuneration. Unquoted Share Rights 491,017
|
| 31 Oct 2025 | Ben Dingle | Issued | 354,210 | $61,600 |
Director remuneration. Unquoted Share Rights 833,312
|
| 31 Oct 2025 | Craig Silbery | Issued | 350,990 | $61,040 |
Director remuneration. Unquoted Share Rights 825,736
|
| 12 Mar 2025 | Craig Silbery | Buy | 30,000 | $5,736 |
On-market trade.
|
| 11 Mar 2025 | Craig Silbery | Buy | 10,000 | $1,912 |
On-market trade.
|
| 07 Mar 2025 | Craig Silbery | Buy | 20,000 | $3,824 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Ben McFarlane Dingle | Non-Executive ChairmanNon-Executive Director | Oct 2023 |
Mr Dingle brings commercial expertise in the dairy nutritional sector as co-founder of New Zealand's Synlait Group, established in 1999. He played a role in Synlait Milk's IPO in 2013 and led the development of large-scale dairy operations on the Canterbury Plains, totaling approximately 15,000 cows and irrigation schemes. Prior to Synlait, Ben owned and managed dairy operations in the Waikato region.
|
| Ms Elizabeth Smith (Liz) | Non-Executive Director | Jul 2024 |
Ms Smith's executive career includes Corporate Finance Partner roles at William Buck and Grant Thornton, as well as audit experience at Ernst & Young. She has experience in finance and accounting, strategy, M&A, risk and governance, with experience advising businesses. She is the Chair of the Group's Risk Committee and a member of the Group's People & Culture Committee.
|
| Mr Craig Silbery | Non-Executive Director | Oct 2023 |
Mr Silbery founded and led Life Space Group from start-up to exit via its sale to Guangzhou-based By-Health in 2018. Life-Space was built on a core foundation of probiotic formulas for infants and pregnant women, underpinned by Human Microbiome science. Craig is currently the founder and CEO of ilume, a wearable pet health venture, and serves as Managing Director of Specialty Probiotics Australia Pty Ltd.
|
| Mr Meng (Leo) Zhang | Non-Executive Director | May 2025 |
Mr Zhang is a business leader and entrepreneur with over a decade of cross-border experience in brand management, international trade and corporate governance. Leo joined H&S Group as a Partner in 2020 and currently serves as a Director and CEO of the H&S Global Brand Center (GBC), overseeing a portfolio of owned and strategic partner brands. He played a role for BTNATURE, BRAUER and NUTRITION29 across China's cross-border e-commerce (CBEC) sector and Southeast Asia. He began his journey in 2014 with the founding of TOP Warehouse. The business served over 600 retail partners and reached a network of more than 100,000 daigou secotr before its integration into H&S Group.
|
| Ms Tamara Barr | Company Secretary | Feb 2022 |
-
|
| Mick Myers | Chief Operating Officer and Chief Financial Officer |
-
|
|
| Tamara Barr | Company Secretary |
-
|
|
| David Curie | General Manager Commercial |
-
|
|
| Roberta Barbiellini | General Manager Practitioner |
-
|
|
| Helen Hovenga | Head of People and Culture |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| H&S Investments Australia Pty Ltd <H&S Investment Unit A/C> | 53,131,133 | 34.15% |
| 402339 Pty Ltd <The Whiti A/C> | 37,853,680 | 24.33% |
| Brauer Natural Medicine Pty Ltd | 22,435,898 | 14.42% |
| HSBC Custody Nominees (Australia) Limited | 13,074,321 | 8.40% |
| Mr Craig Silbery | 5,035,370 | 3.24% |
| Mr Craig Silbery <Silbery Super Fund A/C> | 2,271,561 | 1.46% |
| Gigo Investment Pty Ltd <Gigo A/C> | 1,374,949 | 0.88% |
| Cw Investment Holdings Pty Ltd <Cw Investment Holdings A/C> | 1,030,000 | 0.66% |
| Kirwood Capital Direct Investments 1 Pty Ltd <Kirwood Cap Direct Invest 1> | 1,000,000 | 0.64% |
| Finclear Services Pty Ltd <Superhero Securities A/C> | 958,360 | 0.62% |
| Powers Pty Ltd | 900,000 | 0.58% |
| Top End Enterprises Pty Ltd <Atkins Family A/C> | 892,644 | 0.57% |
| Ataturk Investments Pty Ltd | 831,765 | 0.53% |
| Mf & Sa Super Pty Ltd <Mf & Sa Super A/C> | 600,000 | 0.39% |
| Bk Custodian Pty Ltd <Earle/Blackwell Family A/C> | 589,714 | 0.38% |
| Daho Pty Ltd <The Dhb S/F A/C> | 450,000 | 0.29% |
| Justin Breheny | 370,684 | 0.24% |
| Just Beaut Pty Ltd <Myers Family Super Fund A/C> | 333,333 | 0.21% |
| C&L Chen Pty Ltd <C&L Chen Li Sf A/C> | 322,159 | 0.21% |
| Breheny Enterprises Pty Ltd <Breheny Investments A/C> | 308,904 | 0.20% |
